Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Plos One|August 4, 2009
Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2aIoannis Karakikes, Maengjo Kim, Lahouaria Hadri, et al.Gynecologic Oncology|April 3, 2026
Molecular heterogeneity of endometrial cancer in the real-world: Biomarker patterns by tumor stage, histology, and molecular subtypeRutugandha Paranjpe, Cai Chen, Yezhou Sun, et al.Frontiers in Oncology|March 16, 2026
<i>BRCA</i> genetic testing and treatment patterns for patients with HER2-negative early-stage breast cancer in the US community settingKathryn E Mishkin, Yezhou Sun, Ke Meng, et al.Urologic Oncology|January 18, 2006
Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American menDieudonne Bangsi, Junying Zhou, Yezhou Sun, et al.Journal of the American Society of Nephrology : JASN|September 9, 2008
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosisShaolin Shi, Liping Yu, Celine Chiu, et al.Diabetes|December 1, 2016
Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease SusceptibilityHaiying Qi, Gabriella Casalena, Shaolin Shi, et al.Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 8, 2011
Differential gene expression in patients with amyotrophic lateral sclerosisAlexander Shtilbans, Soon-Gang Choi, Mary E Fowkes, et al.Oncology and Therapy|July 12, 2025
Clinical Burden of Recurrent Disease in High-Risk Endometrial CancerKalé Kponee-Shovein, Vimalanand S Prabhu, Yan Song, et al.Journal of Medical Economics|October 22, 2024
Real-world perioperative treatment patterns and burden of recurrent disease in patients with high-risk endometrial cancer: a SEER-Medicare studyVimalanand S Prabhu, Kalé Kponee-Shovein, Mu Cheng, et al.Journal of Medical Economics|December 9, 2024
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare studyJagadeswara Rao Earla, Kalé Kponee-Shovein, Allison W Kurian, et al.Pageof 3